Medical Induction for Mid trimester Abortion: A Hospital-Based Descriptive Cross-sectional Study

被引:0
作者
Sharma, Jyotshna [1 ]
Tiwari, Sanjeeb [2 ]
Pokhrel, Manoj [1 ]
Lama, Lhakpa [1 ]
机构
[1] Kathmandu Med Coll Teaching Hosp, Dept Obstet & Gyanecol, Kathmandu, Nepal
[2] TU, Dept Gen Practice & Emergency Med, Inst Med, Maharajgunj Med Campus, Kathmandu, Nepal
关键词
abortion; dilation and evacuation; medical induction; MIFEPRISTONE; TERMINATION; PREGNANCY; PROSTAGLANDIN; MISOPROSTOL;
D O I
10.31729/jnma.5502
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Second trimester abortion is known as termination of pregnancy from 13-28 weeks of gestation which can be further divided into early second trimester as 13-22 weeks and late as 23-28 weeks. In our study we have limited up to early second trimester. We intend to see the success rate of combination of mifepristone and misoprostol for medical induction, median time required for expulsion, complication and need of dilation and evacuation in some cases. This study also aims to give a review of current literature in mid trimester abortion with respect to efficacy, complication and also to provide evidencebase recommendation for safe regimens for mid trimester pregnancy termination. Methods: This was hospital-based descriptive cross-sectional study conducted among 40 pregnant women at second trimester admitted for termination of pregnancy in Kathmandu medical collage teaching hospital for the period of six month. Ethical approval was taken from the Institutional Review Committee of Kathmandu Medical College (Ref: 2207202002). Convenient sampling was done. All the pregnant women who need to terminate their pregnancy at second trimester (13-22weeks) were admitted at Kathmandu Medical College Teaching hospital for termination of pregnancy were included in the study. Results: Among the 40 women, who had termination of pregnancy at second trimester 37(92.5%) had successful medical termination whereas 3 (7.5%) needed dilatation and evacuation. Conclusions: The combination of Mifepristone and Misoprostol have excellent result for termination of pregnancy if appropriately used after evaluating the patient with minimal complications.
引用
收藏
页码:794 / 797
页数:4
相关论文
共 11 条
[1]  
Aniteye Patience, 2011, Afr J Reprod Health, V15, P47
[2]   Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases [J].
Ashok, PW ;
Templeton, A ;
Wagaarachchi, PT ;
Flett, GMM .
CONTRACEPTION, 2004, 69 (01) :51-58
[3]   A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy [J].
Dabash, Rasha ;
Chelli, Hela ;
Hajri, Selma ;
Shochet, Tara ;
Raghavan, Sheila ;
Winikoff, Beverly .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2015, 130 (01) :40-44
[4]   Second Trimester Medical Abortion with Mifepristone-Misoprostol and Misoprostol Alone: A Review of Methods and Management [J].
Gewell-Danielsson, Kristina ;
Lalitkumar, Sujata .
REPRODUCTIVE HEALTH MATTERS, 2008, 16 (31) :162-172
[5]  
Karki A, 2015, NEPAL J OBSTET GYNAE, V10, P25
[6]   Mid-trimester induced abortion: a review [J].
Lalitkumar, S. ;
Bygdeman, M. ;
Gemzell-Danielsson, K. .
HUMAN REPRODUCTION UPDATE, 2007, 13 (01) :37-52
[7]   Immediate adverse events after second trimester medical termination of pregnancy: results of a nationwide registry study [J].
Mentula, Maarit J. ;
Niinimaki, Maarit ;
Suhonen, Satu ;
Hemminki, Elina ;
Gissler, Mika ;
Heikinheimo, Oskari .
HUMAN REPRODUCTION, 2011, 26 (04) :927-932
[8]   Unsafe abortion in 2008: global and regional levels and trends [J].
Shah, Iqbal ;
Ahman, Elisabeth .
REPRODUCTIVE HEALTH MATTERS, 2010, 18 (36) :90-101
[9]  
TEMPLETON A, 1990, BRIT J OBSTET GYNAEC, V97, P480
[10]   MEDICAL TERMINATION OF EARLY-PREGNANCY WITH MIFEPRISTONE (RU-486) FOLLOWED BY A PROSTAGLANDIN ANALOG - STUDY IN 16,369 WOMEN [J].
ULMANN, A ;
SILVESTRE, L ;
CHEMAMA, L ;
REZVANI, Y ;
RENAULT, M ;
AGUILLAUME, CJ ;
BAULIEU, EE .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1992, 71 (04) :278-283